A cluster-randomised controlled feasibility trial evaluating the Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS)

Author:

Hynes Sinéad M.1ORCID,Dwyer Christopher P.2ORCID,Alvarez-Iglesias Alberto1ORCID,Rogers Fionnuala3ORCID,Joyce Robert1ORCID,Oglesby Megan1ORCID,Moses Anusha4ORCID,Bane Eimear1ORCID,Counihan Timothy J.1ORCID,Charamba Beatrice5ORCID,Group COB-MS PPI Advisory1

Affiliation:

1. University of Galway

2. Technological University of the Shannon

3. Cardiff University

4. University of Twente

5. Staburo GmbH

Abstract

Abstract Introduction: There is a high prevalence of cognitive difficulties in MS, but despite this, there are few programmes targeting cognition that focus on the ability to function well in everyday life. The Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS), an occupation-focused cognitive intervention, was developed to address this. It focuses on both the functional difficulties and the wide-ranging symptoms that present in MS. Objective: Here we report on the results of a cluster-randomised controlled feasibility trial (ISRCTN11462710; registered 4th September 2019) evaluating the COB-MS in terms of feasibility and initial efficacy as a cognitive intervention for people with MS. Method: Data was collected from people with MS experiencing cognitive difficulties at baseline, post-intervention, 12-weeks, and 6-month follow-up. The primary outcome measure was the Goal Attainment Scaling at 12 weeks. Data was also collected in cognition, quality of life, and mood. Results: One hundred and eighteen people with MS and cognitive difficulties were randomised to either usual care (n=60) or COB-MS intervention (n=58). Ninety-four participants were retained at 6-month follow-up. Those allocated to the COB-MS group had a significant improvement in the primary outcome compared to the control condition. The COB-MS was found to be feasible, including trial procedures and protocol. Data indicates that the COB-MS is accepted by participants and had positive impacts on daily life. Progression criteria have been met. Conclusion: The results provide a strong basis for a pathway to a future definitive trial of COB-MS, with respect to both feasibility and preliminary, clinical efficacy.

Funder

Health Research Board

Publisher

Research Square Platform LLC

Reference57 articles.

1. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Wallin MT;Lancet Neurol,2019

2. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS;Walton C;Multiple Scler J,2020

3. DeLuca J. Recommendations for cognitive screening and management in multiple sclerosis care;Kalb R;Multiple Scler J

4. Diagnosis and treatment of multiple sclerosis: a review;McGinley MP;JAMA,2021

5. Cognition in multiple sclerosis: State of the field and priorities for the future;Sumowski JF;Neurology,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3